A new screening instrument has the potential to more accurately identify fetal alcohol spectrum disorder (FASD), reducing missed and erroneous diagnoses in affected children and facilitating treatment and support, a new study suggests. Prenatal alcohol exposure (PAE) is a known cause of birth and growth defects and neurobehavioral issues.
Improved accuracy of screening tools for fetal alcohol spectrum disorder may lead to faster diagnosis
A new screening instrument has the potential to more accurately identify fetal alcohol spectrum disorder (FASD), reducing missed and erroneous diagnoses in affected children and facilitating treatment and support, a new study suggests. Prenatal alcohol exposure (PAE) is a known cause of birth and growth defects and neurobehavioral issues.